Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Human Embryonic Stem Cells Market, by Region, 2018-2026 (USD Billion)
1.2.2. Human Embryonic Stem Cells Market, by Application, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Embryonic Stem Cells Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Embryonic Stem Cells Market Dynamics
3.1. Human Embryonic Stem Cells Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Human Embryonic Stem Cells Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Human Embryonic Stem Cells Market, by Application
5.1. Market Snapshot
5.2. Global Human Embryonic Stem Cells Market by Application, Performance - Potential Analysis
5.3. Global Human Embryonic Stem Cells Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
5.4. Human Embryonic Stem Cells Market, Sub Segment Analysis
5.4.1. Regenerative Medicine
5.4.2. Stem Cell Biology Research
5.4.3. Tissue Engineering
5.4.4. Toxicology Testing
Chapter 6. Global Human Embryonic Stem Cells Market, Regional Analysis
6.1. Human Embryonic Stem Cells Market, Regional Market Snapshot
6.2. North America Human Embryonic Stem Cells Market
6.2.1. U.S. Human Embryonic Stem Cells Market
6.2.1.1. Application breakdown estimates & forecasts, 2016-2026
6.2.2. Canada Human Embryonic Stem Cells Market
6.3. Europe Human Embryonic Stem Cells Market Snapshot
6.3.1. U.K. Human Embryonic Stem Cells Market
6.3.2. Germany Human Embryonic Stem Cells Market
6.3.3. Rest of Europe Human Embryonic Stem Cells Market
6.4. Asia-Pacific Human Embryonic Stem Cells Market Snapshot
6.4.1. China Human Embryonic Stem Cells Market
6.4.2. India Human Embryonic Stem Cells Market
6.4.3. Japan Human Embryonic Stem Cells Market
6.4.4. Rest of Asia Pacific Human Embryonic Stem Cells Market
6.5. Latin America Human Embryonic Stem Cells Market Snapshot
6.5.1. Brazil Human Embryonic Stem Cells Market
6.5.2. Mexico Human Embryonic Stem Cells Market
6.6. Rest of The World Human Embryonic Stem Cells Market

Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Astellas Pharma Inc/ Ocata Therapeutics
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. Stemcell Technologies Inc.
7.2.3. Biotime, Inc. / Cell Cure Neurosciences LTD
7.2.4. Thermo Fisher Scientific, Inc.
7.2.5. CellGenix GmbH
7.2.6. ESI BIO
7.2.7. PromoCell GmbH
7.2.8. Lonza Group AG
7.2.9. Kite Pharma
7.2.10. Cynata Therapeutics Ltd
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption